1009 related articles for article (PubMed ID: 32035755)
21. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
[TBL] [Abstract][Full Text] [Related]
22. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.
Reyes JL; Herzog CA; Yan H; Roetker NS; Wetmore JB
J Cardiovasc Pharmacol Ther; 2022; 27():10742484221142220. PubMed ID: 36472155
[TBL] [Abstract][Full Text] [Related]
23. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.
Subramanya V; Claxton JS; Lutsey PL; MacLehose RF; Chen LY; Chamberlain AM; Norby FL; Alonso A
BMC Cardiovasc Disord; 2021 Dec; 21(1):598. PubMed ID: 34915858
[TBL] [Abstract][Full Text] [Related]
25. Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation.
Park S; Je NK
J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):57-64. PubMed ID: 31405298
[TBL] [Abstract][Full Text] [Related]
26. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.
Ardeshirrouhanifard S; An H; Goyal RK; Raji MA; Segal JB; Alexander GC; Mehta HB
Pharmacotherapy; 2022 May; 42(5):375-386. PubMed ID: 35364622
[TBL] [Abstract][Full Text] [Related]
27. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
28. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
[TBL] [Abstract][Full Text] [Related]
29. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
[TBL] [Abstract][Full Text] [Related]
30. Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.
Chen ML; Parikh NS; Merkler AE; Kleindorfer DO; Bhave PD; Levitan EB; Soliman EZ; Kamel H
J Am Heart Assoc; 2019 Feb; 8(4):e010661. PubMed ID: 30741594
[TBL] [Abstract][Full Text] [Related]
31. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
32. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
Briasoulis A; Inampudi C; Akintoye E; Alvarez P; Panaich S; Vaughan-Sarrazin M
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622591
[TBL] [Abstract][Full Text] [Related]
33. Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010.
Shroff GR; Solid CA; Herzog CA
J Am Heart Assoc; 2014 Jun; 3(3):e000756. PubMed ID: 24895161
[TBL] [Abstract][Full Text] [Related]
34. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
Navar AM; Kolkailah AA; Overton R; Shah NP; Rousseau JF; Flaker GC; Pignone MP; Peterson ED
J Am Heart Assoc; 2022 Nov; 11(22):e026723. PubMed ID: 36346063
[TBL] [Abstract][Full Text] [Related]
35. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016.
Newman TV; Chen N; He M; Saba S; Hernandez I
Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136
[TBL] [Abstract][Full Text] [Related]
37. Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation.
Guo J; Gabriel N; Magnani JW; Essien UR; Gellad WF; Brooks MM; Trinquart L; Benjamin EJ; Hernandez I
Front Public Health; 2021; 9():780185. PubMed ID: 34805085
[No Abstract] [Full Text] [Related]
38. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
[TBL] [Abstract][Full Text] [Related]
39. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
[TBL] [Abstract][Full Text] [Related]
40. Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer's Disease and the General Population in Australia.
Ilomäki J; Fanning L; Keen C; Sluggett JK; Page AT; Korhonen MJ; Meretoja A; Mc Namara KP; Bell JS
J Alzheimers Dis; 2019; 70(3):733-745. PubMed ID: 31256129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
